Organism name | Diospyros abyssinica |
---|---|
Genus | Diospyros |
Family | Ebenaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Diospyros abyssinica |
---|---|
Linked NCBI taxonomy ID | 413718 |
Linked level | species |
Family in NCBI taxonomy | Ebenaceae |
---|---|
ID | 19955 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003749
![]() |
Lupeol
/ Lupenol / (+)-Lupenol |
CHEMBL289191
CHEMBL459702 |
C010480
|
3 / 0 / 0 | 2 / 6 | No. 23 | No. 51 |
![]() |
C00003741
![]() |
Betulinic acid
|
CHEMBL269277
CHEMBL71690 CHEMBL519059 CHEMBL1318530 CHEMBL2005635 |
C002070
|
34 / 17 / 14 | 10 / 2 | No. 23 | No. 51 |
![]() |
C00003740
![]() |
Betulin
|
CHEMBL23236
CHEMBL140040 CHEMBL1610940 CHEMBL2000891 CHEMBL2069124 |
C002503
|
18 / 16 / 17 | 0 / 2 | No. 23 | No. 51 |
![]() |
C00002831
![]() |
Isodiospyrin
|
CHEMBL1992900
|
C409666
|
No. 312 |
![]() |
|||
C00002816
![]() |
Euclein
/ Diospyrin |
CHEMBL242550
|
C043546
|
No. 312 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P11387 | DNA topoisomerase 1 | Isomerase | C00003740 C00003741 C00003749 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003740 C00003741 C00003749 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003740 C00003741 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00003740 C00003741 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003740 C00003741 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003740 C00003741 | 0 / 0 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003740 C00003741 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003740 C00003741 | 1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00003740 C00003741 | 11 / 10 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003740 C00003741 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003740 C00003741 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00003740 C00003741 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003740 C00003741 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003740 C00003741 | 1 / 0 |
P15121 | Aldose reductase | Enzyme | C00003741 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00003740 | 3 / 1 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003749 | 0 / 0 |
P08151 | Zinc finger protein GLI1 | Unclassified protein | C00003741 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00003741 | 0 / 0 |
P15559 | NAD(P)H dehydrogenase [quinone] 1 | Enzyme | C00003741 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003741 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00003741 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00003741 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00003741 | 1 / 1 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00003741 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00003740 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00003741 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00003741 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003740 | 0 / 3 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00003741 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003741 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00003741 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003741 | 2 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003740 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00003741 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003741 | 1 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00003741 | 0 / 0 |
Q9UBT2 | SUMO-activating enzyme subunit 2 | Enzyme | C00003741 | 0 / 0 |
Q9UBE0 | SUMO-activating enzyme subunit 1 | Unclassified protein | C00003741 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00003741
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00003741
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00003741
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003741
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00003741
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003741
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00003741
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00003741
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00003741
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00003741
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00003749
|
5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00003749
|
OMIM | preferred title | UniProt |
---|---|---|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D008103 | Liver Cirrhosis |
C00003741
|
D008545 | Melanoma |
C00003741
|
D003110 | Colonic Neoplasms |
C00003740
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00003740
|
D006528 | Carcinoma, Hepatocellular |
C00003749
|
D009202 | Cardiomyopathies |
C00003749
|
D006937 | Hypercholesterolemia |
C00003749
|
D009374 | Neoplasms, Experimental |
C00003749
|
D012878 | Skin Neoplasms |
C00003749
|
D014947 | Wounds and Injuries |
C00003749
|